2021
DOI: 10.14366/usg.20067
|View full text |Cite
|
Sign up to set email alerts
|

Current status of image-based surveillance in hepatocellular carcinoma

Abstract: Although the overall prognosis of patients with hepatocellular carcinoma (HCC) remains poor, curative treatment may improve the survival of patients diagnosed at an early stage through surveillance. Accordingly, ultrasonography (US)-based HCC surveillance programs proposed in international society guidelines are now being implemented and regularly updated based on the latest evidence to improve their efficacy. Recently, other imaging modalities such as magnetic resonance imaging have shown potential as alterna… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 82 publications
0
12
0
Order By: Relevance
“…Q2 liver ultrasound (US) is the standard surveillance modality of patients at risk of hepatocellular carcinoma (HCC) development and is endorsed by all international guidelines. 1 Nevertheless, despite its high accessibility and acceptability, the sensitivity of US to detect early stage tumors is suboptimal, 2 leading to surveillance failure and impaired survival. Several factors can explain these disappointing results; they can be related to the patient (male gender, overweight, bowel gas), underlying liver disease (alcohol-related liver disease, liver heterogeneity, impaired liver function), or the pattern of the lesion itself (size, margins, echogenicity, location).…”
Section: B Iannualmentioning
confidence: 99%
“…Q2 liver ultrasound (US) is the standard surveillance modality of patients at risk of hepatocellular carcinoma (HCC) development and is endorsed by all international guidelines. 1 Nevertheless, despite its high accessibility and acceptability, the sensitivity of US to detect early stage tumors is suboptimal, 2 leading to surveillance failure and impaired survival. Several factors can explain these disappointing results; they can be related to the patient (male gender, overweight, bowel gas), underlying liver disease (alcohol-related liver disease, liver heterogeneity, impaired liver function), or the pattern of the lesion itself (size, margins, echogenicity, location).…”
Section: B Iannualmentioning
confidence: 99%
“…The likelihood of inadequate ultrasound quality is significantly higher in overweight or obese patients [ 57 ]. Furthermore, tumor-related factors, such as subcapsular location, small size, and infiltrative tumor type, can significantly impair the sensitivity of ultrasound [ 58 ]. In this context, another important issue is the quality of the ultrasound equipment and the experience of the examiner.…”
Section: Screening For Hepatocellular Carcinomamentioning
confidence: 99%
“…In addition to this, 20% of US examinations for patients with cirrhosis are of inadequate quality to rule out the presence of HCC, mostly due to US artifacts, inadequate US penetration and patient-related characteristics, such as obesity, Child B/C cirrhosis and alcohol or NASH related cirrhosis. Furthermore, there are some areas of the liver that are unreliable for US examination, such as the subcapsular regions [ 134 ]. In this context, another important issue is the quality of the US equipment and the experience of the ultrasonographer [ 133 ].…”
Section: Diagnostic Approachmentioning
confidence: 99%